2022
DOI: 10.1007/s11916-022-01021-1
|View full text |Cite
|
Sign up to set email alerts
|

Tramadol Use in Perioperative Care and Current Controversies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 21 publications
0
7
0
Order By: Relevance
“…Tramadol is an inhibitor of serotonin and norepinephrine reuptake and has a μ-receptor excitatory effect (Grond and Sablotzki, 2004;Ogbemudia et al, 2022). One study had performed painful stimulation of the nasal mucosa of 18 healthy volunteers and found that the analgesic effect produced by oral tramadol at night was stronger (Hummel et al, 1995); in contrast to this study, we explored the role of daytime variation in the analgesic effect of intravenous tramadol, and the results showed that it was stronger in the morning, than in the afternoon.…”
Section: Morning Afternoon Pmentioning
confidence: 71%
“…Tramadol is an inhibitor of serotonin and norepinephrine reuptake and has a μ-receptor excitatory effect (Grond and Sablotzki, 2004;Ogbemudia et al, 2022). One study had performed painful stimulation of the nasal mucosa of 18 healthy volunteers and found that the analgesic effect produced by oral tramadol at night was stronger (Hummel et al, 1995); in contrast to this study, we explored the role of daytime variation in the analgesic effect of intravenous tramadol, and the results showed that it was stronger in the morning, than in the afternoon.…”
Section: Morning Afternoon Pmentioning
confidence: 71%
“…Because tramadol was associated with fewer intravenous opioid boluses, it served as an effective alternative to strong opioids for postoperative pain. Tramadol is considered safer than common opioids as it has fewer and less severe side effects as well as being significantly less addictive 13–15. Notably, tramadol metabolism is affected by CYP2D6 polymorphism, but given the low prevalence of ultra-rapid metabolizers in the general population, the study did not evaluate this attribute 16.…”
Section: Discussionmentioning
confidence: 99%
“…The equivalent total prescription MME of tramadol and codeine given to operative patients is consistent with their rough equivalence in potency, while the disparity in total prescription MME given to nonoperative patients is not. This may be due to the perception of tramadol as a non-opioid or semi-opioid, resulting in tramadol being prescribed more liberally for subacute or chronic conditions or in patients who report opioid allergy or intolerance, although tramadol itself may cause nausea, drowsiness, and constipation frequently seen in patients with opioid intolerance [ 1 ]. The perception of tramadol as a non-opioid or semi-opioid may also factor into the preferential choice for prescribing this medication when there may be an expectation of a longer duration of treatment.…”
Section: Discussionmentioning
confidence: 99%
“…Despite the ongoing opioid crisis in the United States, opioids continue to remain a mainstay of perioperative and nonoperative pain management [ 1 ]. While not an opioid, tramadol is converted in the body to an active metabolite with Mu opioid receptor affinity, and thus, has opioid-like adverse effects, notably respiratory depression and dependence [ 2 ].…”
Section: Introductionmentioning
confidence: 99%